Does PERTUZUMAB Cause Myelosuppression? 1,311 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,311 reports of Myelosuppression have been filed in association with PERTUZUMAB (PERJETA). This represents 6.0% of all adverse event reports for PERTUZUMAB.
1,311
Reports of Myelosuppression with PERTUZUMAB
6.0%
of all PERTUZUMAB reports
3
Deaths
637
Hospitalizations
How Dangerous Is Myelosuppression From PERTUZUMAB?
Of the 1,311 reports, 3 (0.2%) resulted in death, 637 (48.6%) required hospitalization, and 56 (4.3%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PERTUZUMAB. However, 1,311 reports have been filed with the FAERS database.
What Other Side Effects Does PERTUZUMAB Cause?
Diarrhoea (3,343)
Off label use (1,886)
Fatigue (1,672)
Nausea (1,669)
Disease progression (1,142)
Vomiting (1,096)
Dyspnoea (987)
Neuropathy peripheral (983)
Pyrexia (926)
Neutropenia (856)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which PERTUZUMAB Alternatives Have Lower Myelosuppression Risk?
PERTUZUMAB vs PERTUZUMAB\TRASTUZUMAB
PERTUZUMAB vs PETROLATUM
PERTUZUMAB vs PEVONEDISTAT
PERTUZUMAB vs PEXIDARTINIB
PERTUZUMAB vs PHENACETIN